RxDoctor Payments Data

Natella Rakhmanina

Pediatric Infectious Diseases · Washington, DCNPI 1043397524

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $31,452 of the $35,751 with a category attached, or 88.0%. Viiv Healthcare Company accounts for 72.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $21,714 and has fallen 99.8% since, to $52 in 2025.

$35,751in general payments, 2019–2025

Across 27 payments — averaging $1324.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$26K
  • Merck$7K
  • Gilead$3K
$396,843in research payments, 2019–2025

Across 83 payments — averaging $4781.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$265K
  • Merck$83K
  • Viiv Healthcare Company$46K
  • Pfizer$2K

What the payments were for

  • Consulting fees$31,45288%
  • Travel & lodging$3,51610%
  • Food & beverage$7832%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company14$25,996
Merck10$7,122
Gilead3$2,633

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric infectious diseases providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other pediatric infectious diseases in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →